Supports clinical oncology trials in cancer prevention and control in community settings. Funds investigator-initiated research in supportive, palliative and end-of-life care. Coordinates with other NCI programs to conduct clinical oncology research projects in the community setting.
On This Page
- All Heading 2s will automatically be pulled in to this list.
- Do not edit the content on this template.
Major Programs
Staff List
| Photo | Name, Email, Phone | Room | Group(s)/Office |
|---|---|---|---|
 |
Heckman-Stoddard, Brandy, Ph.D., M.P.H. brandy.heckman-stoddard@nih.gov 240-276-7048 |
5E334 | Chief
|
Breast and Gynecologic Cancer
Acting Chief | Community Oncology and Prevention Trials |
 |
Lee, Beverly beverly.lee@nih.gov |
5E532 | Program Officer | Community Oncology and Prevention Trials |
 |
Lee, Cecilia, Dr.P.H., RN cecilia.lee@nih.gov 240-276-7152 |
5E516 | Nurse Consultant | Community Oncology and Prevention Trials |
| Maxwell, Pamela pamela.maxwell@nih.gov 240-276-7081 |
5E434 | Program Specialist | Community Oncology and Prevention Trials | |
 |
McCarty, Larae larae.mccarty@nih.gov 240-276-5777 |
5E322 | Program Specialist
|
Community Oncology and Prevention Trials
Early Detection |
 |
Parker, Bernard, M.D., FACP bernard.parker@nih.gov 240-276-5533 |
5E448 | Program Officer | Community Oncology and Prevention Trials |
 |
Streck, Brennan, Ph.D., RN, M.P.H. brennan.streck@nih.gov 240-276-7050 |
5E430 | Program Officer
|
Breast and Gynecologic Cancer
Program Officer | Community Oncology and Prevention Trials |
 |
Voss, Alyssa, M.P.H. alyssa.voss@nih.gov 240-204-3107 |
Writer/Editor
|
Office of the Director
Community Oncology and Prevention Trials |
|
 |
White, Vanessa A., M.P.H. vanessa.white@nih.gov 240-276-6163 |
5E524 | Program Officer
|
Breast and Gynecologic Cancer
Program Officer | Community Oncology and Prevention Trials |
Grants
| PI Name | PI Organization Sort descending | Title | Grant Number | Program Official |
|---|---|---|---|---|
| Kroetz, Deanna L | Ohio State University |
Sphingolipid Signaling and Chemotherapy-Induced Peripheral Neurotoxicity | 5R01CA261068-06 | Rachel Altshuler, Ph.D. |
| Staff, Nathan P | Mayo Clinic Rochester |
Investigating the role of MAP2 in chemotherapy-induced peripheral neurotoxicity | 5R01CA275870-04 | Rachel Altshuler, Ph.D. |
| Goode, Diana J | University Of New England |
Novel expression of MHC class II on DRG neurons and its role in promoting antinociceptive CD4+ T cells in females during chemotherapy-induced peripheral neuropathy | 5R01CA267554-04 | Rachel Altshuler, Ph.D. |
| Wang, Jing | New York University School Of Medicine |
Optimizing the use of ketamine to reduce chronic postsurgical pain | 3UH3CA261067-05S1 | Brennan Streck, Ph.D., RN, M.P.H. |